TOP NEWS
ENFORCEMENT & COMPLIANCE
LITIGATION
Kirkland Stops Repping Novartis After Regeneron Sought DQ
By Bryan Koenig
A New York federal judge accepted the withdrawal Thursday of the entire Kirkland & Ellis LLP team that recently joined Novartis Pharma's legal team battling antitrust allegations over the eye medication Eylea, just a week after plaintiff Regeneron Pharmaceuticals sought their disqualification over an "unthinkable" conflict of interest by the lawyers, whose firm previously represented Regeneron.
2 documents attached |
Read full article »
| Save to favorites »
Hims & Hers Face Investor Suits Over Wegovy Collab
By Sydney Price
Telehealth company Hims & Hers Health Inc. has been hit with investors' proposed class actions accusing it of exploiting its partnership with Novo Nordisk, the distributor of weight loss drug Wegovy, to sell "knockoff" drugs, causing Hims shares to fall 35% when Novo Nordisk announced earlier this week the collaboration had been terminated.
Complaint attached |
Read full article »
| Save to favorites »
PEOPLE
EXPERT ANALYSIS
LEGAL INDUSTRY
|